These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Two new therapeutic principles in the management of breast cancer and colorectal cancer: selective oral aromatase inhibition and thymidilate synthase inhibition]. Internist (Berl); 1997 Mar; 38(3 Suppl Selektive):1-16. PubMed ID: 9541667 [No Abstract] [Full Text] [Related]
3. Toremifene and letrozole for advanced breast cancer. Med Lett Drugs Ther; 1998 Apr; 40(1024):43-5. PubMed ID: 9580744 [No Abstract] [Full Text] [Related]
4. Interactions of antioestrogens and aromatase inhibitors. Schmid P; Possinger K Forum (Genova); 2002; 12(1):45-59. PubMed ID: 12634910 [TBL] [Abstract][Full Text] [Related]
5. Aromatase inhibitors in breast cancer. Smith IE; Dowsett M N Engl J Med; 2003 Jun; 348(24):2431-42. PubMed ID: 12802030 [No Abstract] [Full Text] [Related]
7. [New developments in the hormonal treatment of breast cancer in postmenopausal women]. Trunet P; Marty M Bull Cancer; 1999 Oct; 86(10):815-20. PubMed ID: 10572232 [TBL] [Abstract][Full Text] [Related]
8. The use of raltitrexed (tomudex) in a patient with 5-fluorouracil induced myocardial ischaemia. Nutting C; Folkes A Clin Oncol (R Coll Radiol); 1999; 11(1):66. PubMed ID: 10194593 [No Abstract] [Full Text] [Related]
9. Raltitrexed, a novel folate-based thymidylate synthase inhibitor, for the treatment of acute leukemia: is this drug active against acute myelogenous leukemia? Takemura Y; Kobayashi H; Miyachi H Int J Hematol; 2000 Jul; 72(1):112-4. PubMed ID: 10979221 [No Abstract] [Full Text] [Related]
10. New breast cancer drug. Brink S US News World Rep; 2001 Dec; 131(26):52. PubMed ID: 11793594 [No Abstract] [Full Text] [Related]
11. Aromatase inhibitors for hormonal therapy of early-stage breast cancer. Traina TA; Dickler MN Curr Opin Investig Drugs; 2004 Jun; 5(6):605-10. PubMed ID: 15242248 [TBL] [Abstract][Full Text] [Related]
12. Inhibitors of steroidogenic enzymes for the treatment of breast cancer. Dowsett M J Steroid Biochem Mol Biol; 1991 Nov; 39(5B):805-9. PubMed ID: 1954170 [TBL] [Abstract][Full Text] [Related]
13. Aromatase inhibitors for breast cancer: lessons from the laboratory. Johnston SR; Dowsett M Nat Rev Cancer; 2003 Nov; 3(11):821-31. PubMed ID: 14668813 [No Abstract] [Full Text] [Related]
15. New endocrine approaches in the treatment of breast cancer. von Minckwitz G; Kaufmann M Biomed Pharmacother; 1998; 52(3):122-32. PubMed ID: 9755805 [TBL] [Abstract][Full Text] [Related]
16. Update on endocrine therapy for breast cancer. Buzdar AU; Hortobagyi G Clin Cancer Res; 1998 Mar; 4(3):527-34. PubMed ID: 9533518 [TBL] [Abstract][Full Text] [Related]
17. Clinical use of aromatase inhibitors in the treatment of advanced breast cancer. Trunet PF; Vreeland F; Royce C; Chaudri HA; Cooper J; Bhatnagar AS J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):241-5. PubMed ID: 9365196 [TBL] [Abstract][Full Text] [Related]
18. Use of estrogen antagonists and aromatase inhibitors in endometriosis. Viganò P; Mangioni S; Odorizzi MP; Chiodini A; Rocca S; Chiodo I Curr Opin Investig Drugs; 2003 Oct; 4(10):1209-12. PubMed ID: 14649213 [TBL] [Abstract][Full Text] [Related]
19. Drugs may improve long-term outcomes after breast cancer. Mayo Clin Health Lett; 2004 Mar; 22(3):4. PubMed ID: 15000065 [No Abstract] [Full Text] [Related]
20. [Superiority of letrozole compared with tamoxifen as first line therapy of postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group]. Illiger HJ Strahlenther Onkol; 2002 Feb; 178(2):111-3. PubMed ID: 11942036 [No Abstract] [Full Text] [Related] [Next] [New Search]